Artificial sweeteners and cancer risk in a network of case–control studies
Open Access
- 16 October 2006
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 18 (1) , 40-44
Abstract
Background: The role of sweeteners on cancer risk has been widely debated over the last few decades. To provide additional information on saccharin and other sweeteners (mainly aspartame), we considered data from a large network of case–control studies. Methods: An integrated network of case–control studies has been conducted between 1991 and 2004 in Italy. Cases were 598 patients with incident, histologically confirmed cancers of the oral cavity and pharynx, 304 of the oesophagus, 1225 of the colon, 728 of the rectum, 460 of the larynx, 2569 of the breast, 1031 of the ovary, 1294 of the prostate and 767 of the kidney (renal cell carcinoma). Controls were 7028 patients (3301 men and 3727 women) admitted to the same hospitals as cases for acute, non-neoplastic disorders. Odds ratios (ORs), and the corresponding 95% confidence intervals (CIs), were derived by unconditional logistic regression models. Results: The ORs for consumption of saccharin were 0.83 (95% CI 0.30–2.29) for cancers of the oral cavity and pharynx, 1.58 (95% CI 0.59–4.25) for oesophageal, 0.95 (95% CI 0.67–1.35) for colon, 0.93 (95% CI 0.60–1.45) for rectal, 1.55 (95% CI 0.76–3.16) for laryngeal, 1.01 (95% CI 0.77–1.33) for breast, 0.46 (95% CI 0.29–0.74) for ovarian, 0.91 (95% CI 0.59–1.40) for prostate and 0.79 (95% CI 0.49–1.28) for kidney cancer. The ORs for consumption of other sweeteners, mainly aspartame, were 0.77 (95% CI 0.39–1.53) for cancers of the oral cavity and pharynx, 0.77 (95% CI 0.34–1.75) for oesophageal, 0.90 (95% CI 0.70–1.16) for colon, 0.71 (95% CI 0.50–1.02) for rectal, 1.62 (95% CI 0.84–3.14) for laryngeal, 0.80 (95% CI 0.65–0.97) for breast, 0.75 (95% CI 0.56–1.00) for ovarian, 1.23 (95% CI 0.86–1.76) for prostate and 1.03 (95% CI 0.73–1.46) for kidney cancer. A significant inverse trend in risk for increasing categories of total sweeteners was found for breast and ovarian cancer, and a direct one for laryngeal cancer. Conclusion: The present work indicates a lack of association between saccharin, aspartame and other sweeteners and the risk of several common neoplasms.Keywords
This publication has 29 references indexed in Scilit:
- Consumption of sweet foods and breast cancer risk in ItalyAnnals of Oncology, 2005
- Does an apple a day keep the oncologist away?Annals of Oncology, 2005
- Food groups and risk of prostate cancer in ItalyInternational Journal of Cancer, 2004
- Food groups and laryngeal cancer risk: A case‐control study from Italy and SwitzerlandInternational Journal of Cancer, 2002
- Intake of saccharin, aspartame, acesulfame K and cyclamate in Italian teenagers: present levels and projectionsFood Additives & Contaminants, 1999
- Reproducibility of an Italian food frequency questionnaire for cancer studies: Results for specific food itemsEuropean Journal of Cancer, 1993
- The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologiesCarcinogenesis, 1981
- Artificial Sweetener Use and Bladder Cancer: A Case-Control StudyScience, 1980
- Artificial Sweeteners and Cancer of the Lower Urinary TractNew England Journal of Medicine, 1980
- ARTIFICIAL SWEETENERS AND HUMAN BLADDER CANCERThe Lancet, 1977